<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-11-01" modified="2023-09-13" version="106" xmlns="http://uniprot.org/uniprot">
  <accession>P05834</accession>
  <accession>Q7M024</accession>
  <name>MCBA_ECOLX</name>
  <protein>
    <recommendedName>
      <fullName>Bacteriocin microcin B17</fullName>
      <shortName>MccB17</shortName>
    </recommendedName>
  </protein>
  <gene>
    <name type="primary">mcbA</name>
  </gene>
  <organism>
    <name type="scientific">Escherichia coli</name>
    <dbReference type="NCBI Taxonomy" id="562"/>
    <lineage>
      <taxon>Bacteria</taxon>
      <taxon>Pseudomonadota</taxon>
      <taxon>Gammaproteobacteria</taxon>
      <taxon>Enterobacterales</taxon>
      <taxon>Enterobacteriaceae</taxon>
      <taxon>Escherichia</taxon>
    </lineage>
  </organism>
  <geneLocation type="plasmid">
    <name>IncFII pMccB17</name>
  </geneLocation>
  <reference key="1">
    <citation type="journal article" date="1986" name="Proteins" volume="1" first="230" last="238">
      <title>The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine.</title>
      <authorList>
        <person name="Davagnino J."/>
        <person name="Herrero M."/>
        <person name="Furlong D."/>
        <person name="Moreno F."/>
        <person name="Kolter R."/>
      </authorList>
      <dbReference type="PubMed" id="3329729"/>
      <dbReference type="DOI" id="10.1002/prot.340010305"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>PARTIAL PROTEIN SEQUENCE</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1989" name="J. Bacteriol." volume="171" first="1126" last="1135">
      <title>DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17.</title>
      <authorList>
        <person name="Genilloud O."/>
        <person name="Moreno F."/>
        <person name="Kolter R."/>
      </authorList>
      <dbReference type="PubMed" id="2644225"/>
      <dbReference type="DOI" id="10.1128/jb.171.2.1126-1135.1989"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1987" name="Mol. Microbiol." volume="1" first="195" last="201">
      <title>An E. coli promoter induced by the cessation of growth.</title>
      <authorList>
        <person name="Conell N."/>
        <person name="Han Z."/>
        <person name="Moreno F."/>
        <person name="Kolter R."/>
      </authorList>
      <dbReference type="PubMed" id="2835580"/>
      <dbReference type="DOI" id="10.1111/j.1365-2958.1987.tb00512.x"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14</scope>
  </reference>
  <reference key="4">
    <citation type="book" date="1993" name="Peptides 1992" first="117" last="118" publisher="Escom Science Publishers" city="Leiden">
      <title>Isolation and structure elucidation of the 43-peptide antibiotic microcin B17.</title>
      <editorList>
        <person name="Schneider C.H."/>
        <person name="Eberles A.N."/>
      </editorList>
      <authorList>
        <person name="Bayer A."/>
        <person name="Stevanovic S."/>
        <person name="Freund S."/>
        <person name="Metzger J.W."/>
        <person name="Jung G."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 27-69</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="4519" last="4523">
      <title>Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.</title>
      <authorList>
        <person name="Yorgey P."/>
        <person name="Lee J."/>
        <person name="Koerdel J."/>
        <person name="Vivas E."/>
        <person name="Warner P."/>
        <person name="Jebaratnam D."/>
        <person name="Kolter R."/>
      </authorList>
      <dbReference type="PubMed" id="8183941"/>
      <dbReference type="DOI" id="10.1073/pnas.91.10.4519"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 27-38</scope>
    <scope>POST-TRANSLATIONAL MODIFICATIONS</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1991" name="EMBO J." volume="10" first="467" last="476">
      <title>The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase.</title>
      <authorList>
        <person name="Vizan J.L."/>
        <person name="Hernandez-Chico C."/>
        <person name="del Castillo I."/>
        <person name="Moreno F."/>
      </authorList>
      <dbReference type="PubMed" id="1846808"/>
      <dbReference type="DOI" id="10.1002/j.1460-2075.1991.tb07969.x"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="7">
    <citation type="journal article" date="1998" name="Chem. Biol." volume="5" first="217" last="228">
      <title>Role of the microcin B17 propeptide in substrate recognition: solution structure and mutational analysis of McbA1-26.</title>
      <authorList>
        <person name="Roy R.S."/>
        <person name="Kim S."/>
        <person name="Baleja J.D."/>
        <person name="Walsh C.T."/>
      </authorList>
      <dbReference type="PubMed" id="9545435"/>
      <dbReference type="DOI" id="10.1016/s1074-5521(98)90635-4"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 1-26</scope>
  </reference>
  <comment type="function">
    <text evidence="1">This glycine-rich peptide antibiotic inhibits DNA replication in many enteric bacteria, that leads to induction of the SOS repair system, massive DNA degradation and cell death. B17 inhibits type II topoisomerase by trapping an enzyme - DNA cleavable complex.</text>
  </comment>
  <comment type="PTM">
    <text>The processed N-terminus does not resemble a typical secretion signal sequence.</text>
  </comment>
  <comment type="PTM">
    <text>Maturation of thiazole and oxazole containing antibiotics involves the enzymatic condensation of a Cys, Ser or Thr with the alpha-carbonyl of the preceding amino acid to form a thioether or ether bond, then dehydration to form a double bond with the alpha-amino nitrogen. Thiazoline or oxazoline rings are dehydrogenated to form thiazole or oxazole rings.</text>
  </comment>
  <dbReference type="EMBL" id="M15469">
    <property type="protein sequence ID" value="AAA24141.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="M24253">
    <property type="protein sequence ID" value="AAA72741.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X06417">
    <property type="protein sequence ID" value="CAA29725.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="PIR" id="A25219">
    <property type="entry name" value="MIEC77"/>
  </dbReference>
  <dbReference type="PIR" id="A58375">
    <property type="entry name" value="A58375"/>
  </dbReference>
  <dbReference type="RefSeq" id="WP_001535752.1">
    <property type="nucleotide sequence ID" value="NZ_VRWA01000056.1"/>
  </dbReference>
  <dbReference type="PDB" id="2MLP">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=1-26"/>
  </dbReference>
  <dbReference type="PDB" id="6GOS">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A=1-69"/>
  </dbReference>
  <dbReference type="PDB" id="6GRG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.35 A"/>
    <property type="chains" value="A=1-69"/>
  </dbReference>
  <dbReference type="PDB" id="6GRH">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.85 A"/>
    <property type="chains" value="A=1-46"/>
  </dbReference>
  <dbReference type="PDBsum" id="2MLP"/>
  <dbReference type="PDBsum" id="6GOS"/>
  <dbReference type="PDBsum" id="6GRG"/>
  <dbReference type="PDBsum" id="6GRH"/>
  <dbReference type="AlphaFoldDB" id="P05834"/>
  <dbReference type="SMR" id="P05834"/>
  <dbReference type="EvolutionaryTrace" id="P05834"/>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031640">
    <property type="term" value="P:killing of cells of another organism"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008156">
    <property type="term" value="P:negative regulation of DNA replication"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="NCBIfam" id="NF041037">
    <property type="entry name" value="microcin_B17"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0044">Antibiotic</keyword>
  <keyword id="KW-0929">Antimicrobial</keyword>
  <keyword id="KW-0078">Bacteriocin</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0236">DNA replication inhibitor</keyword>
  <keyword id="KW-0614">Plasmid</keyword>
  <keyword id="KW-0883">Thioether bond</keyword>
  <feature type="propeptide" id="PRO_0000002772" evidence="2 3">
    <location>
      <begin position="1"/>
      <end position="26"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000002773" description="Bacteriocin microcin B17">
    <location>
      <begin position="27"/>
      <end position="69"/>
    </location>
  </feature>
  <feature type="cross-link" description="Oxazole-4-carboxylic acid (Gly-Ser)" evidence="2">
    <location>
      <begin position="39"/>
      <end position="40"/>
    </location>
  </feature>
  <feature type="cross-link" description="Thiazole-4-carboxylic acid (Ser-Cys)" evidence="2">
    <location>
      <begin position="40"/>
      <end position="41"/>
    </location>
  </feature>
  <feature type="cross-link" description="Thiazole-4-carboxylic acid (Gly-Cys)" evidence="2">
    <location>
      <begin position="47"/>
      <end position="48"/>
    </location>
  </feature>
  <feature type="cross-link" description="Thiazole-4-carboxylic acid (Gly-Cys)" evidence="2">
    <location>
      <begin position="50"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="cross-link" description="Thiazole-4-carboxylic acid (Gly-Cys)" evidence="2">
    <location>
      <begin position="54"/>
      <end position="55"/>
    </location>
  </feature>
  <feature type="cross-link" description="Oxazole-4-carboxylic acid (Cys-Ser)" evidence="2">
    <location>
      <begin position="55"/>
      <end position="56"/>
    </location>
  </feature>
  <feature type="cross-link" description="Oxazole-4-carboxylic acid (Gly-Ser)" evidence="2">
    <location>
      <begin position="61"/>
      <end position="62"/>
    </location>
  </feature>
  <feature type="cross-link" description="Oxazole-4-carboxylic acid (Gly-Ser)" evidence="2">
    <location>
      <begin position="64"/>
      <end position="65"/>
    </location>
  </feature>
  <feature type="strand" evidence="5">
    <location>
      <begin position="9"/>
      <end position="14"/>
    </location>
  </feature>
  <feature type="helix" evidence="5">
    <location>
      <begin position="16"/>
      <end position="20"/>
    </location>
  </feature>
  <feature type="strand" evidence="4">
    <location>
      <begin position="22"/>
      <end position="24"/>
    </location>
  </feature>
  <evidence type="ECO:0000269" key="1">
    <source>
      <dbReference type="PubMed" id="1846808"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="8183941"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0007829" key="4">
    <source>
      <dbReference type="PDB" id="2MLP"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="5">
    <source>
      <dbReference type="PDB" id="6GRH"/>
    </source>
  </evidence>
  <sequence length="69" mass="6013" checksum="0B1D159A832638A8" modified="1988-11-01" version="1" precursor="true">MELKASEFGVVLSVDALKLSRQSPLGVGIGGGGGGGGGGSCGGQGGGCGGCSNGCSGGNGGSGGSGSHI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>